"Global Pharmacogenetic Testing Market Overview:
Global Pharmacogenetic Testing Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Pharmacogenetic Testing Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Pharmacogenetic Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Pharmacogenetic Testing Market:
The Pharmacogenetic Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Pharmacogenetic Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Pharmacogenetic Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Pharmacogenetic Testing market has been segmented into:
Polymerase Chain Reaction (PCR
By Application, Pharmacogenetic Testing market has been segmented into:
Cardiology
Gastroenterology
Endocrinology
Immunology & Hypersensitivity
Gynecology
Oncology
Neurology
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Pharmacogenetic Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Pharmacogenetic Testing market.
Top Key Players Covered in Pharmacogenetic Testing market are:
Abbott Laboratories
Admera Health
Agena Bioscience
BiogeniQ
Bio-Rad Laboratoriesinc.
Cepheid
Gene by Gene Ltd
Genomic Health
Illuminainc.
Laboratory Corporation of America Holdings (LabCorp)
Myriad Geneticsinc.
OneOme
LLC
OPKO Healthinc.
Quest Diagnostics Incorporated
Roche Molecular Diagnostics
Sonic Healthcare
Thermo Fisher Scientific Inc.
23andMeinc.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Pharmacogenetic Testing Market by Type
4.1 Pharmacogenetic Testing Market Snapshot and Growth Engine
4.2 Pharmacogenetic Testing Market Overview
4.3 Polymerase Chain Reaction (PCR
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Polymerase Chain Reaction (PCR: Geographic Segmentation Analysis
Chapter 5: Pharmacogenetic Testing Market by Application
5.1 Pharmacogenetic Testing Market Snapshot and Growth Engine
5.2 Pharmacogenetic Testing Market Overview
5.3 Cardiology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cardiology: Geographic Segmentation Analysis
5.4 Gastroenterology
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Gastroenterology: Geographic Segmentation Analysis
5.5 Endocrinology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Endocrinology: Geographic Segmentation Analysis
5.6 Immunology & Hypersensitivity
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Immunology & Hypersensitivity: Geographic Segmentation Analysis
5.7 Gynecology
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Gynecology: Geographic Segmentation Analysis
5.8 Oncology
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Oncology: Geographic Segmentation Analysis
5.9 Neurology
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Neurology: Geographic Segmentation Analysis
5.10 and Others
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Pharmacogenetic Testing Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ADMERA HEALTH
6.4 AGENA BIOSCIENCE
6.5 BIOGENIQ
6.6 BIO-RAD LABORATORIESINC.
6.7 CEPHEID
6.8 GENE BY GENE
6.9 LTD.
6.10 GENOMIC HEALTH
6.11 ILLUMINAINC.
6.12 LABORATORY CORPORATION OF AMERICA HOLDINGS (LABCORP)
6.13 MYRIAD GENETICSINC.
6.14 ONEOME
6.15 LLC
6.16 OPKO HEALTHINC.
6.17 QUEST DIAGNOSTICS INCORPORATED
6.18 ROCHE MOLECULAR DIAGNOSTICS
6.19 SONIC HEALTHCARE
6.20 THERMO FISHER SCIENTIFIC INC.
6.21 AND 23ANDMEINC.
Chapter 7: Global Pharmacogenetic Testing Market By Region
7.1 Overview
7.2. North America Pharmacogenetic Testing Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Polymerase Chain Reaction (PCR
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Cardiology
7.2.5.2 Gastroenterology
7.2.5.3 Endocrinology
7.2.5.4 Immunology & Hypersensitivity
7.2.5.5 Gynecology
7.2.5.6 Oncology
7.2.5.7 Neurology
7.2.5.8 and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Pharmacogenetic Testing Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Polymerase Chain Reaction (PCR
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Cardiology
7.3.5.2 Gastroenterology
7.3.5.3 Endocrinology
7.3.5.4 Immunology & Hypersensitivity
7.3.5.5 Gynecology
7.3.5.6 Oncology
7.3.5.7 Neurology
7.3.5.8 and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Pharmacogenetic Testing Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Polymerase Chain Reaction (PCR
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Cardiology
7.4.5.2 Gastroenterology
7.4.5.3 Endocrinology
7.4.5.4 Immunology & Hypersensitivity
7.4.5.5 Gynecology
7.4.5.6 Oncology
7.4.5.7 Neurology
7.4.5.8 and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Pharmacogenetic Testing Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Polymerase Chain Reaction (PCR
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Cardiology
7.5.5.2 Gastroenterology
7.5.5.3 Endocrinology
7.5.5.4 Immunology & Hypersensitivity
7.5.5.5 Gynecology
7.5.5.6 Oncology
7.5.5.7 Neurology
7.5.5.8 and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Pharmacogenetic Testing Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Polymerase Chain Reaction (PCR
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Cardiology
7.6.5.2 Gastroenterology
7.6.5.3 Endocrinology
7.6.5.4 Immunology & Hypersensitivity
7.6.5.5 Gynecology
7.6.5.6 Oncology
7.6.5.7 Neurology
7.6.5.8 and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Pharmacogenetic Testing Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Polymerase Chain Reaction (PCR
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Cardiology
7.7.5.2 Gastroenterology
7.7.5.3 Endocrinology
7.7.5.4 Immunology & Hypersensitivity
7.7.5.5 Gynecology
7.7.5.6 Oncology
7.7.5.7 Neurology
7.7.5.8 and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Pharmacogenetic Testing Scope:
|
Report Data
|
Pharmacogenetic Testing Market
|
|
Pharmacogenetic Testing Market Size in 2025
|
USD XX million
|
|
Pharmacogenetic Testing CAGR 2025 - 2032
|
XX%
|
|
Pharmacogenetic Testing Base Year
|
2024
|
|
Pharmacogenetic Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, Admera Health, Agena Bioscience, BiogeniQ, Bio-Rad Laboratoriesinc., Cepheid, Gene by Gene, Ltd., Genomic Health, Illuminainc., Laboratory Corporation of America Holdings (LabCorp), Myriad Geneticsinc., OneOme, LLC, OPKO Healthinc., Quest Diagnostics Incorporated, Roche Molecular Diagnostics, Sonic Healthcare, Thermo Fisher Scientific Inc., and 23andMeinc..
|
|
Key Segments
|
By Type
Polymerase Chain Reaction (PCR
By Applications
Cardiology
Gastroenterology
Endocrinology
Immunology & Hypersensitivity
Gynecology
Oncology
Neurology
and Others
|
